Phase II Trial of Neoadjuvant Chemotherapy [NCT] With Weekly Nanoparticle Albumin-bound Paclitaxel [Nab-paclitaxel; Abraxane®] in Combination With Carboplatin and Bevacizumab in Women With Clinical Stages I-III Breast Cancer
Phase of Trial: Phase II
Latest Information Update: 12 Jan 2017
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary) ; Carboplatin
- Indications Advanced breast cancer; Breast cancer
- Focus Adverse reactions; Therapeutic Use
- 11 Mar 2014 According to the ClinicalTrials.gov record, status changed from active, no longer recruiting to completed.
- 23 May 2012 companies added in association field as reported by ClinicalTrials.gov.
- 23 May 2012 Planned End Date changed from 1 Jun 2009 to 1 Dec 2012 as reported by ClinicalTrials.gov.